相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of long-term administration of Multi-Strain Probiotic on circulating levels of BDNF, NGF, IL-6 and mental health in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial
Mehran Rahimlou et al.
NUTRITIONAL NEUROSCIENCE (2022)
Effects of Lactobacillus casei Strain T2 (IBRC-M10783) on the Modulation of Th17/Treg and Evaluation of miR-155, miR-25, and IDO-1 Expression in a Cuprizone-Induced C57BL/6 Mouse Model of Demyelination
Saeideh Gharehkhani Digehsara et al.
INFLAMMATION (2021)
Efficacy of probiotics in multiple sclerosis: a systematic review of preclinical trials and meta-analysis of randomized controlled trials
Jinchi Jiang et al.
FOOD & FUNCTION (2021)
A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae
Jinshui Zheng et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2020)
A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis
Laura Calvo-Barreiro et al.
CELLS (2020)
Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
Marina Kleopatra Boziki et al.
BRAIN SCIENCES (2020)
Molecular patterns from a human gut-derivedLactobacillusstrain suppress pathogenic infiltration of leukocytes into the central nervous system
John Michael S. Sanchez et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Gut microorganisms act together to exacerbate inflammation in spinal cords
Eiji Miyauchi et al.
NATURE (2020)
Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity
Theresa L. Montgomery et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Experimental autoimmune encephalomyelitis is associated with changes of the microbiota composition in the gastrointestinal tract
David M. Johanson et al.
SCIENTIFIC REPORTS (2020)
Modulation of experimental autoimmune encephalomyelitis through colonisation of the gut with Escherichia coli
J. E. Libbey et al.
BENEFICIAL MICROBES (2020)
How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process
Leyre Mestre et al.
GUT MICROBES (2020)
Human Commensal Prevotella histicola Ameliorates Disease as Effectively as Interferon-Beta in the Experimental Autoimmune Encephalomyelitis
Shailesh K. Shahi et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?
Hannah M. Kohl et al.
DISEASES (2020)
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
Clare Walton et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study
Damiano Baroncini et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study
Damiano Baroncini et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Next generation probiotics in disease amelioration
Chih-Jung Chang et al.
JOURNAL OF FOOD AND DRUG ANALYSIS (2019)
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis
Katharine Harding et al.
JAMA NEUROLOGY (2019)
Changes in patient-reported outcomes between continuers and discontinuers of disease modifying therapy in patients with multiple sclerosis over age 60
Le H. Hua et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Gut Microbiota Interventions With Clostridium butyricum and Norfloxacin Modulate Immune Response in Experimental Autoimmune Encephalomyelitis Mice
Hao Chen et al.
FRONTIERS IN IMMUNOLOGY (2019)
The gut microbiota perspective for interventions in MS
Magdalena Zoledziewska
AUTOIMMUNITY REVIEWS (2019)
Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: a systematic review
Mohammad Morshedi et al.
JOURNAL OF NEUROINFLAMMATION (2019)
The microbiota regulates murine inflammatory responses to toxin-induced CNS demyelination but has minimal impact on remyelination
Christopher E. McMurran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The Dynamic Interplay between the Gut Microbiota and Autoimmune Diseases
Huihui Xu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomes
Hajime Yano et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Managing Risks with Immune Therapies in Multiple Sclerosis
Moritz Foerster et al.
DRUG SAFETY (2019)
Oral Administration of miR-30d from Feces of MS Patients Suppresses MS-like Symptoms in Mice by Expanding Akkermansia muciniphila
Shirong Liu et al.
CELL HOST & MICROBE (2019)
Immunomodulatory effects of probiotics: Can they be used to treat allergies and autoimmune diseases?
Narges Dargahi et al.
MATURITAS (2019)
How probiotic bacteria influence the motor and mental behaviors as well as immunological and oxidative biomarkers in multiple sclerosis? A double blind clinical trial
Mahmoud Salami et al.
JOURNAL OF FUNCTIONAL FOODS (2019)
Lactobacillus reuteri Reduces the Severity of Experimental Autoimmune Encephalomyelitis in Mice by Modulating Gut Microbiota
Baokun He et al.
FRONTIERS IN IMMUNOLOGY (2019)
A probiotic modulates the microbiome and immunity in multiple sclerosis
Stephanie K. Tankou et al.
ANNALS OF NEUROLOGY (2018)
Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis
Laura Calvo-Barreiro et al.
AUTOIMMUNITY REVIEWS (2018)
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics
Carlos R. Camara-Lemarroy et al.
BRAIN (2018)
Investigation of probiotics in multiple sclerosis
Stephanie K. Tankou et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Multiple Sclerosis: Mechanisms and Immunotherapy
Clare Baecher-Allan et al.
NEURON (2018)
Administration of bifidobacterium and lactobacillus strains modulates experimental myasthenia gravis and experimental encephalomyelitis in Lewis rats
Alessandra Consonni et al.
Oncotarget (2018)
Lactobacillus helveticus SBT2171 Attenuates Experimental Autoimmune Encephalomyelitis in Mice
Maya Yamashita et al.
FRONTIERS IN MICROBIOLOGY (2018)
Investigation of probiotics in multiple sclerosis
Stephanie K. Tankou et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Focus on the gut-brain axis: multiple sclerosis, the intestinal barrier and the microbiome
Carlos R. Camara-Lemarroy et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Probiotics in Autoimmune and Inflammatory Disorders
Yuying Liu et al.
NUTRIENTS (2018)
The hygiene hypothesis in autoimmunity: the role of pathogens and commensals
Jean-Francois Bach
NATURE REVIEWS IMMUNOLOGY (2018)
The Effects of Probiotic Supplementation on Gene Expression Related to Inflammation, Insulin, and Lipids in Patients With Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Omid Reza Tamtaji et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2017)
Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice
Kerstin Berer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Human Gut-Derived Commensal Bacteria Suppress CNS Inflammatory and Demyelinating Disease
Ashutosh Mangalam et al.
CELL REPORTS (2017)
Helminth Immunomodulation in Autoimmune Disease
Taylor B. Smallwood et al.
FRONTIERS IN IMMUNOLOGY (2017)
Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction
Thomas Secher et al.
FRONTIERS IN IMMUNOLOGY (2017)
Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+T cell subset balance
Zohre Salehipour et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial
Ebrahim Kouchaki et al.
CLINICAL NUTRITION (2017)
Alterations of the human gut microbiome in multiple sclerosis
Sushrut Jangi et al.
NATURE COMMUNICATIONS (2016)
Enterococcus faecium strain L-3 and glatiramer acetate ameliorate experimental allergic encephalomyelitis in rats by affecting different populations of immune cells
I. N. Abdurasulova et al.
BENEFICIAL MICROBES (2016)
Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study
Gabriel Bsteh et al.
PLOS ONE (2016)
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
Jun Chen et al.
SCIENTIFIC REPORTS (2016)
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters
Sachiko Miyake et al.
PLOS ONE (2015)
A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and T-reg function
Kiel M. Telesford et al.
GUT MICROBES (2015)
SYRCLE's risk of bias tool for animal studies
Carlijn R. Hooijmans et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Helminth/Parasite Treatment of Multiple Sclerosis
Jorge Correale
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2014)
The Gut Microbiome and the Brain
Leo Galland
JOURNAL OF MEDICINAL FOOD (2014)
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
Colin Hill et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling
Yan Wang et al.
NATURE COMMUNICATIONS (2014)
A commensal bacterial product elicits and modulates migratory capacity of CD39+CD4 T regulatory subsets in the suppression of neuroinflammation
Yan Wang et al.
GUT MICROBES (2014)
Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response
Ho-Keun Kwon et al.
CLINICAL IMMUNOLOGY (2013)
Probiotic upregulation of peripheral IL-17 responses does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis mouse models
Toshihide Kobayashi et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2012)
Multiple sclerosis relapses and depression
Phil Moore et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2012)
The Lactic Acid Bacterium Pediococcus acidilactici Suppresses Autoimmune Encephalomyelitis by Inducing IL-10-Producing Regulatory T Cells
Kazushiro Takata et al.
PLOS ONE (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Oral administration of probiotic bacteria, Lactobacillus casei and Bifidobacterium breve, does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis
Toshihide Kobayashi et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2010)
Central Nervous System Demyelinating Disease Protection by the Human Commensal Bacteroides fragilis Depends on Polysaccharide A Expression
Javier Ochoa-Reparaz et al.
JOURNAL OF IMMUNOLOGY (2010)
Multiple sclerosis: risk factors, prodromes, and potential causal pathways
Sreeram V. Ramagopalan et al.
LANCET NEUROLOGY (2010)
A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease
J. Ochoa-Reparaz et al.
MUCOSAL IMMUNOLOGY (2010)
A Novel Probiotic Mixture Exerts a Therapeutic Effect on Experimental Autoimmune Encephalomyelitis Mediated by IL-10 Producing Regulatory T Cells
Shahram Lavasani et al.
PLOS ONE (2010)
Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis
Javier Ochoa-Reparaz et al.
JOURNAL OF IMMUNOLOGY (2009)
Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis
A. Gajofatto et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
The cuprizone model for demyelination
O. Torkildsen et al.
ACTA NEUROLOGICA SCANDINAVICA (2008)
Effects of Bifidobacterium animalis administered during lactation on allergic and autoimmune responses in rodents
J. Ezendam et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Lactobacillus casei Shirota administered during lactation increases the duration of autoimmunity in rats and enhances lung inflammation in mice
Janine Ezendam et al.
BRITISH JOURNAL OF NUTRITION (2008)
Evaluation of immunomodulation by Lactobacillus casei Shirota:: Immune function, autoimmunity and gene expression
Kirsten A. Baken et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2006)
Mechanisms of disease: the hygiene hypothesis revisited
Francisco Guarner et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)
Environmental risk factors in multiple sclerosis aetiology
RA Marrie
LANCET NEUROLOGY (2004)
分享论文
